Related Experiment Video

Updated: Mar 22, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart
11:45

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

7.1K

Current Status and Perspectives in Stem Cell Therapy for Heart

Fen-Chiung Lin1, Wen-Pin Chen2, Pao-Hsien Chu3

  • 1Graduate Institute of Clinical Medicine, Taipei Medical University; ; Division of Cardiology, Linkou Chang Gung Memorial Hospital; ; College of Medicine, Chung Gung University, Taoyuan, Taiwan.

Acta Cardiologica Sinica
|April 29, 2016
PubMed

Insights

Cardiac cell therapy shows promise for heart failure, despite current limitations. Research into stem cell regeneration strategies is advancing cardiovascular medicine.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Cell Therapy

Background:

  • Heart failure prognosis remains poor despite advancements.
  • Cardiac transplantation is limited by risks and donor shortages.
  • The heart was traditionally considered incapable of regeneration.

Purpose of the Study:

  • To review stem cell sources and biomarkers for cardiac regeneration.
  • To provide information on cardiac cell therapy clinical trials.
  • To highlight the evolving understanding of cardiac regenerative capacity.

Main Methods:

  • Review of preclinical and clinical studies on cell therapy for heart failure.
  • Analysis of various stem cell types and their potential applications.
  • Compilation of data from ongoing cardiac cell therapy clinical trials.

Main Results:

  • Numerous studies explore stem cell potential in regenerating heart tissue.
  • Stem cell-derived cardiomyocyte regeneration is a key research area.
  • No current cardiac cell therapy is conclusively proven effective yet.

Conclusions:

  • Stem cell research offers a promising avenue for treating heart failure.
  • Continued investigation into cardiac cell therapy is crucial for future treatments.
  • Understanding cardiac regenerative capacity is transforming cardiovascular medicine.
Abstract

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

8.3K
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

8.9K

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.5K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.9K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.9K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K